pharma · Immunotherapy · Opioid Analgesic Adverse Reaction
Second Affiliated Hospital
Second Affiliated Hospital of Soochow University
Second Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Immunotherapy, Opioid Analgesic Adverse Reaction, Liver Cancer, Ulcerative Colitis (UC). NovaPharmaNews lin
CN HQ
103 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 103
- Programs
- 4
- Drugs
- 11
- Patents
- 0
Esketamine, Sulfentanil or/and Remifentanil
Unknown · small molecule · Opioid Analgesic Adverse Reaction
Esketamine, Sulfentanil or/and Remifentanil for Opioid Analgesic Adverse Reaction is a Unknown program (small_molecule) at Second Affiliated Hospital of Soochow University with 1 ClinicalTrials.gov record(s).
Internal code ZGuo20200826
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Second Affiliated Hospital of Soochow University
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Opioid Analgesic Adverse Reaction
- Status
- active
- Trials
- 1